Could decitabine treatment impair memory functions in humans?

Medical Hypotheses

Volumn 79, Issue 5, 2012, Pages 639-641

  Aydin, Burc ^a   Hocaoglu, Nil ^a   Gidener, Sedef ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BRAIN DERIVED NEUROTROPHIC FACTOR;

ARTICLE; CLINICAL TRIAL (TOPIC); DNA METHYLATION; DRUG EFFECT; HUMAN; MEMORY DISORDER; MYELODYSPLASTIC SYNDROME; NEUROLOGIC EXAMINATION; PHASE 4 CLINICAL TRIAL (TOPIC); PROTEIN BLOOD LEVEL; STUDY DESIGN; TREATMENT DURATION; TREATMENT RESPONSE;

AZACITIDINE; DNA METHYLATION; ENZYME INHIBITORS; HUMANS; MEMORY DISORDERS;

ANIMALIA;

EID: 84867333272     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.07.042     Document Type: Article

References (33)

1. Day J.J., Sweatt J.D. Epigenetic mechanisms in cognition. Neuron 2011, 70(5):813-829.
2. Weber M., Schübeler D. Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr Opin Cell Biol 2007, 19(3):273-280.
3. Stresemann C., Lyko F. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int J Cancer 2008, 123(1):8-13.
4. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361(6407):31-39.
5. Dityatev A.E., Bolshakov V.Y. Amygdala, long-term potentiation, and fear conditioning. Neuroscientist 2005, 11(1):75-88.
6. D'Hooge R., De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 2001, 36(1):60-90.
7. Maren S. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 2001, 24(1):897-931.
8. Miller C.A., Sweatt J.D. Covalent modification of DNA regulates memory formation. Neuron 2007, 53(6):857-869.
9. Monsey M.S., Ota K.T., Akingbade I.F., Hong E.S., Schafe G.E. Epigenetic alterations are critical for fear memory consolidation and synaptic plasticity in the lateral amygdala. PLoS One 2011, 6(5):e19958.
10. Lubin F.D., Roth T.L., Sweatt J.D. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 2008, 28(42):10576-10586.
11. Levenson J.M., Roth T.L., Lubin F.D., et al. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 2006, 281(23):15763-15773.
12. Feng J., Zhou Y., Campbell S.L., et al. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 2010, 13(4):423-430.
13. Linnarsson S., Björklund A., Ernfors P. Learning deficit in BDNF mutant mice. Eur J Neurosci 1997, 9(12):2581-2587.
14. Hall J., Thomas K.L., Everitt B.J. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci 2000, 3(6):533-535.
15. Bramham C.R., Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. ProgNeurobiol 2005, 76(2):99-125.
16. Heldt S.A., Stanek L., Chhatwal J.P., Ressler K.J. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007, 12(7):656-670.
17. Miller C.A., Gavin C.F., White J.A., et al. Cortical DNA methylation maintains remote memory. Nat Neurosci 2010, 13(6):664-666.
18. Lommatzsch M., Zingler D., Schuhbaeck K., et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005, 26(1):115-123.
19. Ziegenhorn A.A., Schulte-Herbrüggen O., Danker-Hopfe H., et al. Serum neurotrophins - a study on the time course and influencing factors in a large old age sample. Neurobiol Aging 2007, 28(9):1436-1445.
20. Erickson K.I., Prakash R.S., Voss M.W., et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci 2010, 30(15):5368-5375.
21. Gunstad J., Benitez A., Smith J., et al. Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. J Geriatr Psychiatry Neurol 2008, 21(3):166-170.
22. Li G., Peskind E.R., Millard S.P., et al. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One 2009, 4(5):e5424.
23. Garcia-Manero G. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011, 86(6):490-498.
24. Kantarjian H., Oki Y., Garcia-Manero G., et al. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood 2007, 109(1):52-57.
25. Blum W., Klisovic R.B., Hackanson B., et al. Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia. J Clin Oncol 2007, 25(25):3884-3891.
26. Chabot G.G., Rivard G.E., Momparler R.L. Plasma and cerebrospinal fluid pharmacokinetics of 5-aza-2'-deoxycytidine in rabbits and dogs. Cancer Res 1983, 43(2):592-597.
27. Sales A.J., Biojone C., Terceti M.S., Guimarães F.S., Gomes M.V., Joca S.R. Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br J Pharmacol 2011, 164(6):1711-1721.
28. Germing U., Strupp C., Giagounidis A. Clinical features and prognosis of patients with myelodysplastic syndromes. Cancer Treat Rev 2007, 33:S15-S18.
29. Hedden T., Gabrieli J.D. Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 2004, 5(2):87-96.
30. Woodford H.J., George J. Cognitive assessment in the elderly: a review of clinical methods. QJM 2007, 100(8):469-484.
31. Miyajima F., Ollier W., Mayes A., et al. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behav 2008, 7(4):411-417.
32. Ozan E., Okur H., Eker C., Eker O.D., Gönül A.S., Akarsu N. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res Bull 2010, 81(1):61-65.
33. Day J.J., Sweatt J.D. Epigenetic treatments for cognitive impairments. Neuropsychopharmacology 2012, 37(1):247-260.